BioWorld

Oct. 23, 2003

Mutated Amyloid Precursor Protein (APP), Presenilin Genes, Cause Of Early Familial Alzheimer's Disease

AaiPharma Purchases Four Pain Products From Elan For $100M

Other News To Note

ILEX Starts Clofarabine Filing Process, Begins Rolling NDA

In a move to launch its second product in the U.S., ILEX Oncology Inc. filed the first part of a rolling new drug application on Wednesday for Clofarabine to treat refractory or relapsed acute leukemia in children.(BioWorld Today) Read More

Amgen Earnings Up Again; Aranesp Franchise 'Secure'

NIH changes set industry up for workforce, ideas drought

BioWorld

On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...

Today's news in brief

BioWorld

BioWorld briefs for March 6, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for March 6, 2025

Roche looks to grow with sequencing by expansion tech

BioWorld MedTech

Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...

Illustration of Magnet Biomedicine's Trueglue platform

Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology

BioWorld

About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...